vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and EASTERN CO (EML). Click either name above to swap in a different company.
EASTERN CO is the larger business by last-quarter revenue ($55.3M vs $44.9M, roughly 1.2× AbCellera Biologics Inc.). EASTERN CO runs the higher net margin — 1.0% vs -19.9%, a 21.0% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -22.4%). EASTERN CO produced more free cash flow last quarter ($3.1M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -0.6%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
EASTERN COEMLEarnings & Financial Report
China Eastern Airlines is a major airline in China, headquartered in Changning, Shanghai. It is one of the three major airlines in the country, along with Air China and China Southern Airlines.
ABCL vs EML — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $55.3M |
| Net Profit | $-8.9M | $578.9K |
| Gross Margin | — | 22.3% |
| Operating Margin | -63.7% | 3.1% |
| Net Margin | -19.9% | 1.0% |
| Revenue YoY | 788.4% | -22.4% |
| Net Profit YoY | 73.9% | 103.8% |
| EPS (diluted) | $-0.03 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | — | ||
| Q3 25 | $9.0M | $55.3M | ||
| Q2 25 | $17.1M | $70.2M | ||
| Q1 25 | $4.2M | $63.3M | ||
| Q4 24 | $5.0M | $64.3M | ||
| Q3 24 | $6.5M | $71.3M | ||
| Q2 24 | $7.3M | $72.6M | ||
| Q1 24 | $10.0M | $64.6M |
| Q4 25 | $-8.9M | — | ||
| Q3 25 | $-57.1M | $578.9K | ||
| Q2 25 | $-34.7M | $3.4M | ||
| Q1 25 | $-45.6M | $1.9M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | $-51.1M | $-15.3M | ||
| Q2 24 | $-36.9M | $3.5M | ||
| Q1 24 | $-40.6M | $1.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | 22.3% | ||
| Q2 25 | — | 23.3% | ||
| Q1 25 | — | 22.4% | ||
| Q4 24 | — | 23.6% | ||
| Q3 24 | — | 25.5% | ||
| Q2 24 | — | 25.4% | ||
| Q1 24 | — | 23.9% |
| Q4 25 | -63.7% | — | ||
| Q3 25 | -851.8% | 3.1% | ||
| Q2 25 | -290.2% | 4.5% | ||
| Q1 25 | -1479.6% | 5.1% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | -1439.4% | 9.5% | ||
| Q2 24 | -1276.2% | 8.3% | ||
| Q1 24 | -551.5% | 5.3% |
| Q4 25 | -19.9% | — | ||
| Q3 25 | -637.8% | 1.0% | ||
| Q2 25 | -203.3% | 4.9% | ||
| Q1 25 | -1077.2% | 3.1% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | -785.4% | -21.5% | ||
| Q2 24 | -504.3% | 4.8% | ||
| Q1 24 | -408.0% | 3.0% |
| Q4 25 | $-0.03 | — | ||
| Q3 25 | $-0.19 | $0.10 | ||
| Q2 25 | $-0.12 | $0.56 | ||
| Q1 25 | $-0.15 | $0.32 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | $-0.17 | $-2.46 | ||
| Q2 24 | $-0.13 | $0.56 | ||
| Q1 24 | $-0.14 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $9.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $124.3M |
| Total Assets | $1.4B | $220.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | $9.2M | ||
| Q2 25 | $92.4M | $9.1M | ||
| Q1 25 | $159.3M | $10.2M | ||
| Q4 24 | $156.3M | $16.1M | ||
| Q3 24 | $126.6M | $9.7M | ||
| Q2 24 | $148.3M | $2.0M | ||
| Q1 24 | $123.6M | $2.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $42.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $966.9M | — | ||
| Q3 25 | $964.0M | $124.3M | ||
| Q2 25 | $1.0B | $124.4M | ||
| Q1 25 | $1.0B | $121.0M | ||
| Q4 24 | $1.1B | $120.7M | ||
| Q3 24 | $1.1B | $119.2M | ||
| Q2 24 | $1.1B | $136.5M | ||
| Q1 24 | $1.1B | $134.5M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $220.0M | ||
| Q2 25 | $1.4B | $229.4M | ||
| Q1 25 | $1.3B | $232.3M | ||
| Q4 24 | $1.4B | $235.3M | ||
| Q3 24 | $1.4B | $244.2M | ||
| Q2 24 | $1.4B | $255.9M | ||
| Q1 24 | $1.5B | $253.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.35× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $3.1M |
| Free Cash FlowOCF − Capex | $-44.6M | $3.1M |
| FCF MarginFCF / Revenue | -99.4% | 5.5% |
| Capex IntensityCapex / Revenue | 21.9% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 5.38× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $12.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | — | ||
| Q3 25 | $-52.6M | $3.1M | ||
| Q2 25 | $-32.4M | $3.8M | ||
| Q1 25 | $-11.6M | $-1.8M | ||
| Q4 24 | $-108.6M | $11.0M | ||
| Q3 24 | $-28.9M | $-2.9M | ||
| Q2 24 | $-30.0M | $8.4M | ||
| Q1 24 | $-41.7M | $2.8M |
| Q4 25 | $-44.6M | — | ||
| Q3 25 | $-61.5M | $3.1M | ||
| Q2 25 | $-45.8M | $3.0M | ||
| Q1 25 | $-22.2M | $-2.7M | ||
| Q4 24 | $-187.0M | $9.0M | ||
| Q3 24 | $-47.4M | $-7.7M | ||
| Q2 24 | $-50.1M | $7.3M | ||
| Q1 24 | $-65.8M | $1.1M |
| Q4 25 | -99.4% | — | ||
| Q3 25 | -687.0% | 5.5% | ||
| Q2 25 | -267.9% | 4.3% | ||
| Q1 25 | -524.0% | -4.3% | ||
| Q4 24 | -3702.8% | 13.9% | ||
| Q3 24 | -728.4% | -10.8% | ||
| Q2 24 | -683.8% | 10.1% | ||
| Q1 24 | -661.5% | 1.7% |
| Q4 25 | 21.9% | — | ||
| Q3 25 | 99.7% | 0.1% | ||
| Q2 25 | 78.2% | 1.1% | ||
| Q1 25 | 251.1% | 1.3% | ||
| Q4 24 | 1552.7% | 3.2% | ||
| Q3 24 | 284.6% | 6.7% | ||
| Q2 24 | 274.6% | 1.5% | ||
| Q1 24 | 242.5% | 2.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.38× | ||
| Q2 25 | — | 1.09× | ||
| Q1 25 | — | -0.95× | ||
| Q4 24 | — | 8.41× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.40× | ||
| Q1 24 | — | 1.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
